Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:55:21 EST Wed 17 Dec 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Z:VNRX - VOLITIONRX LIMITED - https://www.volitionrx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VNRX - Z0.10.2221·0.26880.10.2421-0.00010.01,074.71731,2960.2404  0.248  0.23350.94  0.2419:00:18Dec 1115 min RT 2¢

Recent Trades - Last 10 of 1296
Time ETExPriceChangeVolume
19:00:18Z0.24-0.00373
18:30:58Z0.24-0.0037200
18:29:56Z0.24-0.003720
18:18:57Z0.24-0.0037500
17:31:27Z0.2428-0.00091
17:31:14Z0.2428-0.0009102
17:30:03Z0.2402-0.0035405
17:16:07Z0.24770.004197
16:57:05Z0.24770.0049
16:52:20Z0.24490.00121

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-12-11 09:00U:VNRXNews ReleaseVolition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment
2025-12-08 09:00U:VNRXNews ReleaseVolition Announces Two Abstracts were Presented at the North America Conference on Lung Cancer
2025-12-04 09:00U:VNRXNews ReleaseVolitionRx Limited Announces Inclusion of its Nu.Q(TM) NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis
2025-11-25 08:45U:VNRXNews ReleaseVolitionRx Limited Announces the First Sale of the Nu.Q(TM) Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use
2025-11-13 16:10U:VNRXNews ReleaseVolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update
2025-11-10 08:45U:VNRXNews ReleaseVolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update
2025-10-17 08:00U:VNRXNews ReleaseVolition Donates Nu.Q(TM) Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs
2025-10-10 08:30U:VNRXNews ReleaseVolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants
2025-10-09 16:05U:VNRXNews ReleaseVolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants
2025-10-02 08:45U:VNRXNews ReleaseVolition Sponsors Upcoming GenomeWeb Webinar
2025-09-29 09:30U:VNRXNews ReleaseVolition Signs Co-Marketing and Services Agreement with Hologic
2025-09-09 08:45U:VNRXNews ReleaseVolition Signs First Human Out Licensing Deal
2025-08-14 16:10U:VNRXNews ReleaseVolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update
2025-08-08 08:30U:VNRXNews ReleaseVolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update
2025-08-04 16:01U:VNRXNews ReleaseVolitionRx Announces Pricing of $1.2 Million Registered Direct Offering
2025-07-16 08:00U:VNRXNews ReleaseNu.Q(TM) Discover Expands Global Adoption and Epigenetic Innovation
2025-07-08 08:00U:VNRXNews ReleaseVolition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes
2025-06-12 08:30U:VNRXNews ReleaseVolition Announces MARS Consortium Clinical Study Suggests Nu.Q(TM) H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure
2025-06-04 21:00U:VNRXNews ReleaseVolition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties
2025-05-19 08:30U:VNRXNews ReleaseVolitionRx Limited Announces Successful Detection of Nucleosomes in Cats